Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
Related Posts
Microsoft Shares Drop 4.5% After Cloud Growth Forecast Falls Short
Microsoft’s cloud growth forecast for the coming quarters fell short of investor expectations, causing its shares to drop 4.5% in…
‘Reboot Your PC’—Microsoft Changes ‘Most Windows Devices’ In June
By Zak Doffman Publication Date: 2026-05-18 19:03:00 All change for Windows AFP via Getty Images Updated on May 18 with…
Finally fixed: Microsoft closes door on a popular Win 11 activation hack
By Sean Endicott Publication Date: 2025-11-13 21:37:00 With Windows 10 reaching the end of mainstream support last month, many are…